Cargando…
Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404796/ https://www.ncbi.nlm.nih.gov/pubmed/28461740 http://dx.doi.org/10.2147/DDDT.S137116 |
_version_ | 1783231650846474240 |
---|---|
author | Thakkar, Disha Dash, Ranjeet Prasad |
author_facet | Thakkar, Disha Dash, Ranjeet Prasad |
author_sort | Thakkar, Disha |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5404796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-54047962017-05-01 Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis Thakkar, Disha Dash, Ranjeet Prasad Drug Des Devel Ther Letter Dove Medical Press 2017-04-20 /pmc/articles/PMC5404796/ /pubmed/28461740 http://dx.doi.org/10.2147/DDDT.S137116 Text en © 2017 Thakkar and Dash. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Letter Thakkar, Disha Dash, Ranjeet Prasad Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis |
title | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis |
title_full | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis |
title_fullStr | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis |
title_full_unstemmed | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis |
title_short | Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis |
title_sort | pharmacokinetic interactions between glimepiride and rosuvastatin in healthy korean subjects: does the slco1b1 or cyp2c9 genetic polymorphism affect these drug interactions? observations and introspection of the bioanalysis |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404796/ https://www.ncbi.nlm.nih.gov/pubmed/28461740 http://dx.doi.org/10.2147/DDDT.S137116 |
work_keys_str_mv | AT thakkardisha pharmacokineticinteractionsbetweenglimepirideandrosuvastatininhealthykoreansubjectsdoestheslco1b1orcyp2c9geneticpolymorphismaffectthesedruginteractionsobservationsandintrospectionofthebioanalysis AT dashranjeetprasad pharmacokineticinteractionsbetweenglimepirideandrosuvastatininhealthykoreansubjectsdoestheslco1b1orcyp2c9geneticpolymorphismaffectthesedruginteractionsobservationsandintrospectionofthebioanalysis |